Cargando…
Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection
BACKGROUND: Oral vancomycin (125 mg qid) is recommended as treatment of severe Clostridium difficile infection (CDI). Higher doses (250 or 500 mg qid) are sometimes recommended for patients with very severe CDI, without supporting clinical evidence. We wished to determine to what extent faecal level...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022836/ https://www.ncbi.nlm.nih.gov/pubmed/21192802 http://dx.doi.org/10.1186/1471-2334-10-363 |